belantamab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
belantamab
Jun 7, 2024, 14:59 |
Blog
Vincent Rajkumar: ASCO24 myeloma papers that I will be highlighting
Vincent Rajkumar shared a post on X: ''First of the NEJM ASCO24 myeloma papers that I…
Jun 2, 2024, 23:06 |
Blog
Vincent Rajkumar: The 4 big myeloma randomized trials to watch out for ASCO24
Vincent Rajkumar shared a post on X: "The 4 big myeloma randomized trials to watch out…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
Feb 22, 2024, 18:58 |
Insight
Manni Mohyuddin: Read this paper carefully, then read it again
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared on…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube